These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 20960865)

  • 1. [Immunosuppressive acidic protein (IAP)].
    Fukazawa H; Yoshida K; Sakurada T
    Nihon Rinsho; 2010 Jul; 68 Suppl 7():756-8. PubMed ID: 20960865
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunosuppressive acidic protein (IAP)].
    Tamura K
    Nihon Rinsho; 1999 Dec; 57 Suppl():532-5. PubMed ID: 10778183
    [No Abstract]   [Full Text] [Related]  

  • 3. [Immunosuppressive acidic protein (IAP) and immunosuppressive substance (ISS) in patients with renal cell carcinoma].
    Yamazaki K; Kumamoto Y; Tsukamoto T; Ohmura K; Miyao N; Yoshioka M; Iwasawa A
    Hinyokika Kiyo; 1991 May; 37(5):467-74. PubMed ID: 1858580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunosuppressive acid protein (IAP)].
    Ikeda H
    Nihon Rinsho; 2005 Aug; 63 Suppl 8():711-2. PubMed ID: 16149619
    [No Abstract]   [Full Text] [Related]  

  • 5. [Inflammatory reaction and laboratory tests: IAP (immunosuppressive acidic protein)].
    Sato T; Sakata Y; Tamura K
    Rinsho Byori; 1990 Mar; 38(3):255-9. PubMed ID: 2190023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of immunosuppressive acid protein in genitourinary malignant diseases].
    Okada S; Kirime S; Kawasaki T; Kanbara A; Kanehara H; Takasaki N; Miyazaki S; Inai S
    Hinyokika Kiyo; 1988 Mar; 34(3):411-8. PubMed ID: 3389287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum immunosuppressive acidic protein doubling time as a prognostic factor for recurrent renal cell carcinoma after nephrectomy.
    Araki K; Igarashi T; Tobe T; Mizoguchi K; Suzuki H; Furuya Y; Ichikawa T; Nakatsu HO; Ito H
    Urology; 2006 Dec; 68(6):1178-82. PubMed ID: 17141843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunosuppressive acidic protein (IAP) and squamous cell carcinoma antigen (SCC) in patients with cervical cancer.
    Battaglia F; Scambia G; Panici PB; Castelli M; Ferrandina G; Foti E; Amoroso M; D'Andrea G; Mancuso S
    Gynecol Oncol; 1994 May; 53(2):176-82. PubMed ID: 8188076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical study on the serum carcinoembryonic antigen, immunosuppressive acidic protein and C-reactive protein levels in patients with adult T cell leukemia].
    Kumagai E; Ogata M; Maeda Y; Kumagai T; Okajima K; Yamaguchi K; Tanoue S
    Rinsho Byori; 1989 Jul; 37(7):769-73. PubMed ID: 2607647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Level of immunosuppressive acidic protein in the fluid of breast cysts].
    Mezi S; Reale MG; Marchei G; Marigliani A; Aloise G; Sallusti E; Mentuccia D; Del Nero A; Izzo P; Modesti M
    G Chir; 1997; 18(11-12):827-30. PubMed ID: 9534338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunosuppressive acidic protein detects high nuclear grade localized renal cell carcinoma.
    Kawata N; Yamaguchi K; Hirakata H; Hachiya T; Yoshida T; Takimoto Y
    Urology; 2005 Oct; 66(4):736-40. PubMed ID: 16230127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Changes of immunosuppressive acidic protein (IAP) in patients treated with total-body hyperthermia].
    Maeta M; Koga S; Shimizu N; Yoshioka H; Wakatsuki T
    Gan To Kagaku Ryoho; 1985 Jan; 12(1):163-5. PubMed ID: 3966808
    [No Abstract]   [Full Text] [Related]  

  • 13. [A study of an immunosuppressive acidic protein (IAP) in patients with a bone tumor].
    Mori O; Yonemura K; Morisawa K
    Gan No Rinsho; 1988 Oct; 34(12):1690-2. PubMed ID: 3193614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative study of immunosuppressive acidic protein (IAP), CA 125 and acute-phase proteins as parameters for ovarian cancer monitoring.
    Koebl H; Tatra G; Bieglmayer C
    Neoplasma; 1988; 35(2):215-20. PubMed ID: 3259680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study of immunosuppressive acidic protein (IAP) in patients with renal cell cancer].
    Shibayama T; Nakazono M; Koyama Y; Deguchi N; Baba S; Jitsukawa S; Murai M; Tazaki H
    Gan No Rinsho; 1984 May; 30(5):481-6. PubMed ID: 6727048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical investigation of serum immunosuppressive acidic protein (IAP) in patients with gastric cancer].
    Kageyama T; Oyabu H; Ohshiba S
    Gan No Rinsho; 1986 Sep; 32(11):1416-20. PubMed ID: 3773269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum proteomic profiling by matrix-assisted laser desorption-ionization time-of-flight mass spectrometry for cancer diagnosis: next steps.
    Diamandis EP
    Cancer Res; 2006 Jun; 66(11):5540-1. PubMed ID: 16740686
    [No Abstract]   [Full Text] [Related]  

  • 18. Cell transfer regimens in patients with highly advanced surgically unresectable non-small cell lung cancer: significantly improved overall survival in patients with lower levels of serum immunosuppressive acidic protein.
    Ebina T; Fujimiya Y
    Lung Cancer; 2008 May; 60(2):246-51. PubMed ID: 17980454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The relationship between serum immunosuppressive acidic protein (IAP) and cellular immunity in the patients with gastric cancer].
    Nakanishi K; Toge T; Hamamoto S; Tanada M; Itagaki E; Kohno H; Yanagawa E; Hattori T
    Gan To Kagaku Ryoho; 1982 Oct; 9(10):1827-31. PubMed ID: 6223588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical evaluation of the serum level of immunosuppressive acidic protein (IAP) and immunosuppressive substance (IS) in gastric cancer patients].
    Sakita M; Yamane T; Kasuga M; Torii T; Imai H; Kageyama N; Fujita Y; Majima S
    Gan To Kagaku Ryoho; 1982 Oct; 9(10):1755-64. PubMed ID: 7184372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.